tiprankstipranks
Masimo Corp. (CH:3M4)
NASDAQ:3M4
Switzerland Market
3M4
Masimo
RESEARCH TOOLSreports

Masimo (3M4) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

3M4 Analyst Ratings

Hold
2Ratings
Hold
0 Buy
2 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Masimo
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

3M4 Stock 12 Month Forecast

Average Price Target

$140.95
Based on 2 Wall Street analysts offering 12 month price targets for Masimo in the last 3 months. The average price target is $140.95 with a high forecast of $140.95 and a low forecast of $140.95. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$140.95Average Price Target$140.95Lowest Price Target$140.95
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on CH:3M4
Jayson Bedford
Raymond James
Raymond James
―
Hold
―
Downgraded
03/27/26
Masimo downgraded to Market Perform from Outperform at Raymond JamesMasimo downgraded to Market Perform from Outperform at Raymond James
Wells Fargo Analyst forecast on CH:3M4
Larry Biegelsen
Wells Fargo
Wells Fargo
CHF140.95
Hold
―
Reiterated
03/17/26
Masimo assumed with an Equal Weight at Wells FargoMasimo assumed with an Equal Weight at Wells Fargo
BTIG Analyst forecast on CH:3M4
Marie Thibault
BTIG
BTIG
―
Hold
―
Downgraded
02/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Masimo (NASDAQ: MASI), Janux Therapeutics Inc (NASDAQ: JANX) and Beta Bionics, Inc. (NASDAQ: BBNX)
Needham Analyst forecast on CH:3M4
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
02/17/26
Analysts Conflicted on These Healthcare Names: Masimo (NASDAQ: MASI) and Medtronic (NYSE: MDT)
Bank of America Securities Analyst forecast on CH:3M4
Travis Steed
Bank of America Securities
Bank of America Securities
―
Hold
―
Reiterated
02/17/26
Analysts Conflicted on These Healthcare Names: Danaher (NYSE: DHR), Cogent Biosciences (NASDAQ: COGT) and Masimo (NASDAQ: MASI)
Stifel Nicolaus Analyst forecast on CH:3M4
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
CHF140.95
Hold
―
Downgraded
02/17/26
Masimo downgraded to Hold from Buy at StifelMasimo downgraded to Hold from Buy at Stifel
Piper Sandler Analyst forecast on CH:3M4
Jason Bednar
Piper Sandler
Piper Sandler
CHF164.44→CHF140.95
Hold
―
Downgraded
02/17/26
Masimo downgraded to Neutral from Overweight at Piper SandlerMasimo downgraded to Neutral from Overweight at Piper Sandler
Jefferies Analyst forecast on CH:3M4
Matthew Taylor
Jefferies
Jefferies
CHF123.73→CHF133.12
Hold
―
Reiterated
08/06/25
Masimo (MASI) Receives a Hold from Jefferies
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on CH:3M4
Jayson Bedford
Raymond James
Raymond James
―
Hold
―
Downgraded
03/27/26
Masimo downgraded to Market Perform from Outperform at Raymond JamesMasimo downgraded to Market Perform from Outperform at Raymond James
Wells Fargo Analyst forecast on CH:3M4
Larry Biegelsen
Wells Fargo
Wells Fargo
CHF140.95
Hold
―
Reiterated
03/17/26
Masimo assumed with an Equal Weight at Wells FargoMasimo assumed with an Equal Weight at Wells Fargo
BTIG Analyst forecast on CH:3M4
Marie Thibault
BTIG
BTIG
―
Hold
―
Downgraded
02/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Masimo (NASDAQ: MASI), Janux Therapeutics Inc (NASDAQ: JANX) and Beta Bionics, Inc. (NASDAQ: BBNX)
Needham Analyst forecast on CH:3M4
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
02/17/26
Analysts Conflicted on These Healthcare Names: Masimo (NASDAQ: MASI) and Medtronic (NYSE: MDT)
Bank of America Securities Analyst forecast on CH:3M4
Travis Steed
Bank of America Securities
Bank of America Securities
―
Hold
―
Reiterated
02/17/26
Analysts Conflicted on These Healthcare Names: Danaher (NYSE: DHR), Cogent Biosciences (NASDAQ: COGT) and Masimo (NASDAQ: MASI)
Stifel Nicolaus Analyst forecast on CH:3M4
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
CHF140.95
Hold
―
Downgraded
02/17/26
Masimo downgraded to Hold from Buy at StifelMasimo downgraded to Hold from Buy at Stifel
Piper Sandler Analyst forecast on CH:3M4
Jason Bednar
Piper Sandler
Piper Sandler
CHF164.44→CHF140.95
Hold
―
Downgraded
02/17/26
Masimo downgraded to Neutral from Overweight at Piper SandlerMasimo downgraded to Neutral from Overweight at Piper Sandler
Jefferies Analyst forecast on CH:3M4
Matthew Taylor
Jefferies
Jefferies
CHF123.73→CHF133.12
Hold
―
Reiterated
08/06/25
Masimo (MASI) Receives a Hold from Jefferies
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Masimo

3 Months
PerPlexity Medical - Instruments and SuppliesTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+0.90%
Copying PerPlexity Medical - Instruments and Supplies's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.90% per trade.
1 Year
PerPlexity Medical - Instruments and SuppliesTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+0.90%
Copying PerPlexity Medical - Instruments and Supplies's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.90% per trade.
2 Years
PerPlexity Medical - Instruments and SuppliesTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+0.90%
Copying PerPlexity Medical - Instruments and Supplies's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

3M4 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
2
2
0
0
0
Buy
7
3
1
0
0
Hold
11
9
8
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
14
9
2
0
In the current month, 3M4 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 3M4 average Analyst price target in the past 3 months is 140.95.
Each month's total comprises the sum of three months' worth of ratings.

3M4 Financial Forecast

3M4 Earnings Forecast

Next quarter’s earnings estimate for 3M4 is $1.13 with a range of $1.11 to $1.15. The previous quarter’s EPS was $1.13. 3M4 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 3M4 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 3M4 is $1.13 with a range of $1.11 to $1.15. The previous quarter’s EPS was $1.13. 3M4 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 3M4 has Performed in-line its overall industry.

3M4 Sales Forecast

Next quarter’s sales forecast for 3M4 is $315.10M with a range of $313.91M to $316.29M. The previous quarter’s sales results were $319.13M. 3M4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 3M4 has Performed in-line its overall industry.
Next quarter’s sales forecast for 3M4 is $315.10M with a range of $313.91M to $316.29M. The previous quarter’s sales results were $319.13M. 3M4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 3M4 has Performed in-line its overall industry.

3M4 Stock Forecast FAQ

What is CH:3M4’s average 12-month price target, according to analysts?
Based on analyst ratings, Masimo Corp.’s 12-month average price target is 140.95.
    What is CH:3M4’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:3M4, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Masimo Corp. a Buy, Sell or Hold?
        Masimo Corp. has a consensus rating of Hold, which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Masimo Corp.’s share price target?
          The average share price target for Masimo Corp. is 140.95. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $140.95 ,and the lowest forecast is $140.95. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Masimo Corp.?
            Masimo Corp.’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
              How can I buy shares of Masimo Corp.?
              To buy shares of CH:3M4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.